The Spectrum of Coagulation Abnormalities in Thyroid Disorders

ABSTRACT

The hemostatic balance is a complex system where the delicate equilibrium is regulated by several factors including hormones. A variety of endocrine disorders have been reported to be associated with coagulation abnormalities, ranging from mild laboratory changes to clinically relevant thrombotic or bleeding manifestations. In this review, we summarize the current knowledge on the main abnormalities of the coagulation and fibrinolytic systems associated with thyroid dysfunctions. Overall, although mostly based on uncontrolled studies, data in the literature suggest that patients with hyperthyroidism or subclinical hypothyroidism have a hypercoagulative state, whereas patients with overt hypothyroidism have a bleeding tendency.

KEYWORDS

Bleeding - thrombosis - hyperthyroidism - hypothyroidism

REFERENCES

• 1 Franchini M, Lippi G, Manzato F, Vescovi P P, Targher G. Hemostatic abnormalities in endocrine and metabolic disorders.  Eur J Endocrinol. 2010;  162 (3) 439-451
• 2 Squizzato A, Gerdes V EA, Ageno W, Büller H R. The coagulation system in endocrine disorders: a narrative review.  Intern Emerg Med. 2007;  2 (2) 76-83
• 3 Squizzato A, Romualdi E, Büller H R, Gerdes V EA. Clinical review: thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review.  J Clin Endocrinol Metab. 2007;  92 (7) 2415-2420
• 4 Franchini M. Hemostasis and thyroid diseases revisited.  J Endocrinol Invest. 2004;  27 (9) 886-892
• 5 Franchini M, Montagnana M, Manzato F, Vescovi P P. Thyroid dysfunction and hemostasis: an issue still unresolved.  Semin Thromb Hemost. 2009;  35 (3) 288-294
• 6 Mina A, Favaloro E J, Koutts J. Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review.  Semin Thromb Hemost. 2007;  33 (8) 798-809
• 7 Marongiu F, Barcellona D, Mameli A, Mariotti S. Thyroid disorders and hypocoagulability.  Semin Thromb Hemost. 2011;  37 (1) 11-16
• 8 Erem C. Thyroid disorders and hypercoagulability.  Semin Thromb Hemost. 2011;  37 (1) 17-26
• 9 Erem C. Coagulation and fibrinolysis in thyroid dysfunction.  Endocrine. 2009;  36 (1) 110-118
• 10 Ford H C, Carter J M. Haemostasis in hypothyroidism.  Postgrad Med J. 1990;  66 (774) 280-284
• 11 Erem C, Kavgaci H, Ersöz H O et al.. Blood coagulation and fibrinolytic activity in hypothyroidism.  Int J Clin Pract. 2003;  57 (2) 78-81
• 12 Hofbauer L C, Heufelder A E. Coagulation disorders in thyroid diseases.  Eur J Endocrinol. 1997;  136 (1) 1-7
• 13 Marongiu F, Cauli C, Mariotti S. Thyroid, hemostasis and thrombosis.  J Endocrinol Invest. 2004;  27 (11) 1065-1071
• 14 Dalton R G, Dewar M S, Savidge G F et al. Hypothyroidism as a cause of acquired von Willebrand's disease.  Lancet. 1987;  1 (8540) 1007-1009
• 15 Blesing N E, Hambley H, McDonald G A. Acquired von Willebrand's disease and hypothyroidism: report of a case presenting with menorrhagia.  Postgrad Med J. 1990;  66 (776) 474-476
• 16 Thornton J G, Parapia L A, Minford A MB. Hypothyroidism and von Willebrand's disease.  Lancet. 1987;  1 (8545) 1314-1315
• 17 Nitu-Whalley I C, Lee C A. Acquired von Willebrand syndrome—report of 10 cases and review of the literature.  Haemophilia. 1999;  5 (5) 318-326
• 18 Michiels J J, Schroyens W, Berneman Z, van der Planken M. Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine.  Clin Appl Thromb Hemost. 2001;  7 (2) 113-115
• 19 Attivissimo L A, Lichtman S M, Klein I. Acquired von Willebrand's syndrome causing a hemorrhagic diathesis in a patient with hypothyroidism.  Thyroid. 1995;  5 (5) 399-401
• 20 Tjan-Heijnen V CG, Harthoorn-Lasthuizen E J, Kurstjens R MA, Koolen M I. A patient with postpartum primary hypothyroidism and acquired von Willebrand's disease.  Neth J Med. 1994;  44 (3) 91-94
• 21 Franchini M, de Gironcoli M, Lippi G et al. Efficacy of desmopressin as surgical prophylaxis in patients with acquired von Willebrand disease undergoing thyroid surgery.  Haemophilia. 2002;  8 (2) 142-144
• 22 Manfredi E, van Zaane B, Gerdes V E, Brandjes D P, Squizzato A. Hypothyroidism and acquired von Willebrand's syndrome: a systematic review.  Haemophilia. 2008;  14 (3) 423-433
• 23 Franchini M, Zugni C, Veneri D et al. High prevalence of acquired von Willebrand's syndrome in patients with thyroid diseases undergoing thyroid surgery.  Haematologica. 2004;  89 (11) 1341-1346
• 24 Palareti G, Biagi G, Legnani C et al. Association of reduced factor VIII with impaired platelet reactivity to adrenalin and collagen after total thyroidectomy.  Thromb Haemost. 1989;  62 (4) 1053-1056
• 25 Myrup B, Bregengård C, Faber J. Primary haemostasis in thyroid disease.  J Intern Med. 1995;  238 (1) 59-63
• 26 Egeberg B O. Influence of thyroid function on the blood clotting system.  Scand J Clin Lab Invest. 1963;  15 1-7
• 27 Rogers II J S, Shane S R, Jencks F S. Factor VIII activity and thyroid function.  Ann Intern Med. 1982;  97 (5) 713-716
• 28 Gullu S, Sav H, Kamel N. Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism.  Eur J Endocrinol. 2005;  152 (3) 355-361
• 29 Meiklejohn D J, Watson H G. Acquired haemophilia in association with organ-specific autoimmune disease.  Haemophilia. 2001;  7 (5) 523-525
• 30 Chadarevian R, Bruckert E, Leenhardt L, Giral P, Ankri A, Turpin G. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism.  J Clin Endocrinol Metab. 2001;  86 (2) 732-737
• 31 Cantürk Z, Cetinarslan B, Tarkun I, Cantürk N Z, Ozden M, Duman C. Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism.  Thyroid. 2003;  13 (10) 971-977
• 32 Özcan M A, Cömlekçi A, Demirkan F et al. Plasma levels of free tissue factor pathway inhibitor in patients with various thyroid disorders.  Thromb Res. 2003;  110 (4) 243-247
• 33 Ochs N, Auer R, Bauer D C et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality.  Ann Intern Med. 2008;  148 (11) 832-845
• 34 Duntas L, Biondi B. New insights into subclinical hypothyroidism and cardiovascular risk.  Semin Thromb Hemost. 2011;  37 (1) 27-34
• 35 Hofbauer L C, Spitzweg C, Schmauss S, Heufelder A E. Graves' disease associated with autoimmune thrombocytopenic purpura.  Arch Intern Med. 1997;  157 (9) 1033-1036
• 36 Cordiano I, Betterle C, Spadaccino C A, Soini B, Girolami A, Fabris F. Autoimmune thrombocytopenia (AITP) and thyroid autoimmune disease (TAD): overlapping syndromes?.  Clin Exp Immunol. 1998;  113 (3) 373-378
• 37 Franchini M, Lippi G, Manzato F, Vescovi P P. Thyroid-associated autoimmune coagulation disorders.  J Thromb Thrombolysis. 2010;  29 (1) 87-91
• 38 Marongiu F, Conti M, Murtas M L et al. Anticardiolipin antibodies in Graves' disease: relationship with thrombin activity in vivo.  Thromb Res. 1991;  64 (6) 745-749
• 39 Hofbauer L C, Spitzweg C, Heufelder A E. Graves' disease associated with the primary antiphospholipid syndrome.  J Rheumatol. 1996;  23 (8) 1435-1437
• 40 Homoncik M, Gessl A, Ferlitsch A, Jilma B, Vierhapper H. Altered platelet plug formation in hyperthyroidism and hypothyroidism.  J Clin Endocrinol Metab. 2007;  92 (8) 3006-3012
• 41 Rogers II J S, Shane S R. Factor VIII activity in normal volunteers receiving oral thyroid hormone.  J Lab Clin Med. 1983;  102 (3) 444-449
• 42 Lippi G, Franchini M, Targher G et al. Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatients.  J Thromb Thrombolysis. 2009;  28 (3) 362-365
• 43 Franchini M, Lippi G, Targher G. Hyperthyroidism and venous thrombosis: a causal or casual association? A systematic literature review.  Clin Appl Thromb Hemost. 2010;  March 22 (Epub ahead of print)
• 44 Erem C, Ersöz H O, Karti S S et al. Blood coagulation and fibrinolysis in patients with hyperthyroidism.  J Endocrinol Invest. 2002;  25 (4) 345-350
• 45 Morishita E, Hashimoto T, Asakura H et al. Increased plasma levels of free tissue factor pathway inhibitor in patients with Graves' disease.  Thromb Haemost. 1998;  79 (5) 919-923
• 46 Erem C, Ucuncu O, Yilmaz M, Kocak M, Nuhoglu I, Ersoz H O. Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism.  Endocrine. 2009;  36 (3) 473-478